Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 42, Issue 10, 2013, Pages 761-768

  Liu, Shu li ^a   Zhong, Shuang shuang ^a   Ye, Dong xia ^a   Chen, Wan tao ^a   Zhang, Zhi yuan ^a   Deng, Jiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

GPRC5A; Immunohistochemistry; Oral squamous cell carcinoma

Indexed keywords

BETA ACTIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR C5A; UNCLASSIFIED DRUG; GPRC5A PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUTH SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ADOLESCENT; ADULT; AGED; CANCER GRADING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PLASMID; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM GRADING; PLASMIDS; RECEPTORS, G-PROTEIN-COUPLED; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84887238187     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12077     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
3. Cheng Y, Lotan R. Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor. J Biol Chem 1998; 273: 35008-15.
4. Tao Q, Fujimoto J, Men T, et al. Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene. J Natl Cancer Inst 2007; 99: 1668-82.
5. Deng J, Fujimoto J, Ye X-F, et al. Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-κB activation in airway epithelium and promotes lung inflammation and tumorigenesis. Cancer Prev Res 2010; 3: 424-37.
6. Odani T, Ito D, Li M-H, et al. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology. Int J Oncol 2006; 28: 619-24.
7. Zhang L, Yang X, Zhong L-P, et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 362-70.
8. Yang X-H, Feng Z-E, Yan M, et al. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer. PLoS ONE 2012; 7: e31601.
9. Toruner GA, Ulger C, Alkan M, et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154: 27-35.
10. Zhang L, Pan H-Y, Zhong L-P, et al. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis. J Oral Pathol Med 2010; 39: 470-6.
11. Shimada K, Uzawa K, Kato M, et al. Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 2005; 92: 1915-21.
12. Xu J, Tian J, Shapiro SD. Normal lung development in RAIG1-deficient mice despite unique lung epithelium-specific expression. Am J Respir Cell Mol Biol 2005; 32: 381-7.
13. Bhutani M, Pathak AK, Fan YH, et al. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 2008; 1: 39-44.
14. Dolle P. Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal 2009; 7: e006.
15. Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. J Cell Physiol 2011; 226: 322-30.
16. Holland LZ. Developmental biology: a chordate with a difference. Nature 2007; 447: 153-5.
17. Kawaguchi J, Mee PJ, Smith AG. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 2005; 36: 758-69.
18. Kennedy KA, Porter T, Mehta V, et al. Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol 2009; 7: 67.
19. Chan EC, Lam SY, Fu KH, Kwong YL. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 2005; 162: 10-20.
20. Virmani AK, Rathi A, Zöchbauer-Müller S, et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst 2000; 92: 1303-7.
21. Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers. Cancer Res 2001; 61: 249-55.
22. 2 Gene in Head and Neck Carcinogenesis. Clin Cancer Res 2004; 10: 1733-42.
23. Nagahata T, Sato T, Tomura A, Onda M, Nishikawa K, Emi M. Identification of RAI3 as therapeutic target for breast cancer. Endocr Relat Cancer 2005; 12: 65-73.